✦ LIBER ✦

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial

✍ Scribed by Lutz Fischer; Pavel Trunečka; Bruno Gridelli; Andre Roy; Alessandro Vitale; Andrés Valdivieso; Evaristo Varo; Daniel Seehofer; Stephen Lynch; Didier Samuel; Bo-Goran Ericzon; Karim Boudjema; Carmen Karpf; Nasrullah Undre

Book ID: 102468691
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 481 KB
Volume: 17
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.22211

No coin nor oath required. For personal study only.

✦ Synopsis

at the time of

📜 SIMILAR VOLUMES

Pharmacokinetics for Once- Versus Twice-

Pharmacokinetics for Once- Versus Twice-Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open-Label Trial

✍ Z. Wlodarczyk; J.-P. Squifflet; M. Ostrowski; P. Rigotti; S. Stefoni; F. Citteri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB

Tacrolimus Once Daily (ADVAGRAF) Versus

Tacrolimus Once Daily (ADVAGRAF) Versus Twice Daily (PROGRAF) in De Novo Renal Transplantation: A Randomized Phase III Study

✍ B. K. Krämer; B. Charpentier; L. Bäckman; H. Tedesco Silva Jr; G. Mondragon-Rami 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Once-Daily Prolonged-Release Tacrolimus

Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation

✍ P. Trunečka; O. Boillot; D. Seehofer; A. D. Pinna; L. Fischer; B.-G. Ericzon; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB

Pharmacokinetics of Once- Versus Twice-D

Pharmacokinetics of Once- Versus Twice-Daily Tacrolimus Formulations in Kidney Transplant Patients Receiving Expanded Criteria Deceased Donor Organs: A Single-Center, Randomized Study

✍ M. Cabello; P. García; M. González-Molina; M.J. Díez de los Rios; M. García-Sáiz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Once-Weekly Exenatide Versus Once- or Tw

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

✍ Davies, M.; Heller, S.; Sreenan, S.; Sapin, H.; Adetunji, O.; Tahbaz, A.; Vora, 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 223 KB

(765): Long-term improvement in physical

(765): Long-term improvement in physical function observed in the ACTION Trial: A randomized, multi-center study of once daily AVINZA® (morphine sulfate extended-release capsules) versus twice daily OxyContin® (oxycodone hydrochloride controlled-release) for modera

✍ R. Rauck; S. Bookbinder; T. Bunker; C. Alftine; S. Gershon; R. Ghalie; E. De Jon 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 35 KB